Electrochemotherapy, a new therapy for patients with skin cancer in Latin America: literature review
DOI:
https://doi.org/10.15343/0104-7809.202448e15462023PKeywords:
Cancer, Dermatology, Electroporation, Surgery, PalliativeAbstract
Electrochemotherapy is an innovative technology used to treat skin and mucosal cancers. It consists of intravenous administration of bleomycin followed by the application of electroporation pulses to the tumor at its margins. These pulses induce the formation of pores in the cell membrane, increasing the cytotoxic efficacy of bleomycin by more than 1,000- fold. As electroporation is a physical phenomenon, different types of tumors can be treated regardless of their histology. Generally, only one treatment session is needed to obtain a satisfactory response. Electrochemotherapy is a good option for recurrent tumors in which other therapies do not provide a response. Additionally, tumors can be shrunk with therapy, allowing for less aggressive surgeries and improving outcomes. Many treatment guidelines have begun to include the use of this non-ablative technique as a new treatment option when other therapies have failed or been rejected by the patient. Treatment is carried out on an outpatient basis with high response rates and few side effects.
Downloads
References
DeVita VT Jr, Rosenberg SA, Lawrence TS. DeVita, Hellman and Rosenberg’s Cancer: Principles and Practice of Oncology [Internet]. LWW; 2022. Available from: https://books.google.com/books/about/DeVita_Hellman_and_Rosenberg_s_Cancer. html?hl=&id=opB4zgEACAAJ
Probst U, Fuhrmann I, Beyer L, Wiggermann P. Electrochemotherapy as a New Modality in Interventional Oncology: A Review. Technol Cancer Res Treat [Internet]. 2018 Jul 9 [cited 2023 Sep 27]; Available from: https://journals.sagepub.com/ doi/10.1177/1533033818785329
Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl [Internet]. 2006 Nov 1;4(11):3–13. Available from: http://www.sciencedirect.com/science/article/pii/ S1359634906001868
Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol [Internet]. 2018 Jul 3 [cited 2023 Sep 27]; Available from: https://www. tandfonline.com/doi/abs/10.1080/0284186X.2018.1454602
Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer Clin Oncol [Internet]. 1991 Jan 1 [cited 2023 Sep 27];27(1):68–72. Available from: http://dx.doi.org/10.1016/0277-5379(91)90064-K
Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin B, Belehradek J Jr, et al. [Electrochemotherapy, a new antitumor treatment: first clinical trial]. C R Acad Sci III [Internet]. 1991;313(13):613–8. Available from: https://www.ncbi.nlm.nih.gov/pubmed/1723647
Insp-ECT [Internet]. [cited 2023 Oct 26]. Available from: https://www.insp-ect.org/
Maglietti F, Tellado M, De Robertis M, Michinski S, Fernández J, Signori E, et al. Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America. Vaccines (Basel) [Internet]. 2020 Sep 17;8(3). Available from: http:// dx.doi.org/10.3390/vaccines8030537
Mir LM. Bases and rationale of the electrochemotherapy. Eur J Cancer Suppl [Internet]. 2006 Nov 1;4(11):38–44. Available from: http://www.sciencedirect.com/science/article/pii/S1359634906001923
Miklavcic D, Corovic S, Pucihar G, Pavselj N. Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. Eur J Cancer Suppl [Internet]. 2006 Nov 1;4(11):45–51. Available from: http://www.sciencedirect.com/science/ article/pii/S1359634906001935
Wichtowski M, Murawa D, Kulcenty K, Zaleska K. Electrochemotherapy in Breast Cancer - Discussion of the Method and Literature Review. Breast Care [Internet]. 2017 Dec;12(6):409–14. Available from: http://dx.doi.org/10.1159/000479954
Matthiessen LW, Muir T, Gehl J. Electrochemotherapy for larger malignant tumors. In: Clinical Aspects of Electroporation [Internet]. New York, NY: Springer New York; 2011. p. 103–13. Available from: https://link.springer.com/10.1007/978-1-4419-8363-3_9
Campana LG, Edhemovic I, Soden D, Perrone AM, Scarpa M, Campanacci L, et al. Electrochemotherapy - Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration. Eur J Surg Oncol [Internet]. 2019 Feb;45(2):92–102. Available from: http://dx.doi.org/10.1016/j.ejso.2018.11.023
Sersa G, Cemazar M. Vascular-disrupting action of electrochemotherapy: Mode of action and therapeutic implications. In: Clinical Aspects of Electroporation [Internet]. New York, NY: Springer New York; 2011. p. 83–91. Available from: https://link.springer. com/10.1007/978-1-4419-8363-3_7
Henze J, Maintz D, Persigehl T. RECIST 1.1, irRECIST 1.1, and mRECIST: How to Do. 2016. Current Radiology Reports, 4, 1-11.
Sersa G, Teissie J, Cemazar M, Signori E, Kamensek U, Marshall G, et al. Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother [Internet]. 2015 Oct;64(10):1315–27. Available from: http:// dx.doi.org/10.1007/s00262-015-1724-2
Tellado M, De Robertis M, Montagna D, Giovannini D, Salgado S, Michinski S, et al. Electrochemotherapy Plus IL-2+IL-12 Gene Electrotransfer in Spontaneous Inoperable Stage III-IV Canine Oral Malignant Melanoma. Vaccines (Basel) [Internet]. 2023 May 27;11(6). Available from: http://dx.doi.org/10.3390/vaccines11061033
Milicevic S, Cemazar M, Ivancic AK, Gasljevic G, Bosnjak M, Sersa G, et al. Electrochemotherapy of Melanoma Cutaneous Metastases in Organ Transplant Recipients: A Systematic Review of Preclinical and Clinical Studies. Int J Mol Sci [Internet]. 2023 May 6 [cited 2023 Oct 23];24(9):8335. Available from: https://www.mdpi.com/1422-0067/24/9/8335
Campana LG, Peric B, Mascherini M, Spina R, Kunte C, Kis E, et al. Combination of Pembrolizumab with Electrochemotherapy in Cutaneous Metastases from Melanoma: A Comparative Retrospective Study from the InspECT and Slovenian Cancer Registry. Cancers [Internet]. 2021 Aug 25;13(17). Available from: http://dx.doi.org/10.3390/cancers13174289
Clover AJP, Salwa SP, Bourke MG, McKiernan J, Forde PF, O’Sullivan ST, et al. Electrochemotherapy for the treatment of primary basal cell carcinoma; A randomised control trial comparing electrochemotherapy and surgery with five year follow up. Eur J Surg Oncol[Internet]. 2020 May;46(5):847–54. Available from: http://dx.doi.org/10.1016/j.ejso.2019.11.509
Hendel K, Jemec GBE, Haedersdal M, Wiegell SR. Electrochemotherapy with bleomycin for basal cell carcinomas: a systematic review. J Eur Acad Dermatol Venereol [Internet]. 2021 Nov;35(11):2208–15. Available from: http://dx.doi.org/10.1111/jdv.17492
Campana LG, Marconato R, Valpione S, Galuppo S, Alaibac M, Rossi CR, et al. Basal cell carcinoma: 10-year experience with electrochemotherapy. J Transl Med [Internet]. 2017 May 31;15(1):122. Available from: http://dx.doi.org/10.1186/s12967-017-1225-5
1 Recommendations | Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma | Guidance | NICE. [cited 2023 Oct 26]; Available from: https://www.nice.org.uk/guidance/ipg478/chapter/1-Recommendations
Bertino G, Groselj A, Campana LG, Kunte C, Schepler H, Gehl J, et al. Electrochemotherapy for the treatment of cutaneous squamous cell carcinoma: The INSPECT experience (2008-2020). 2022. Frontiers in Oncology, 12, 951662. Available from: https://doi. org/10.3389/fonc.2022.951662
Di Monta G, Caracò C, Simeone E, Grimaldi AM, Marone U, Di Marzo M, et al. Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22-cases retrospective analysis. J Transl Med [Internet]. 2017 Apr 26;15(1):82. Available from: http://dx.doi.org/10.1186/s12967-017-1186-8
Overview | Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma | Guidance | NICE. [cited 2023 Oct 26]; Available from: https://www.nice.org.uk/guidance/ipg478
Jamsek C, Sersa G, Bosnjak M, Groselj A. Long term response of electrochemotherapy with reduced dose of bleomycin in elderly patients with head and neck non-melanoma skin cancer. Radiol Oncol [Internet]. 2020 Mar 1 [cited 2023 Oct 17];54(1):79–85. Available from: https://sciendo.com/pdf/10.2478/raon-2020-0009
Campana LG, Testori A, Mozzillo N, Rossi CR. Treatment of metastatic melanoma with electrochemotherapy. J Surg Oncol [Internet]. 2014 Mar;109(4):301–7. Available from: http://dx.doi.org/10.1002/jso.23512
Kunte C, Letulé V, Gehl J, Dahlstroem K, Curatolo P, Rotunno R, et al. Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT. Br J Dermatol [Internet]. 2017 Jun;176(6):1475–85. Available from: http://dx.doi. org/10.1111/bjd.15340
Petrelli F, Ghidini A, Simioni A, Campana LG. Impact of electrochemotherapy in metastatic cutaneous melanoma: a contemporary systematic review and meta-analysis. Acta Oncol [Internet]. 2022 May 4 [cited 2023 Oct 23]; Available from: https://www.tandfonline. com/doi/abs/10.1080/0284186X.2021.2006776
Recommendations | Melanoma: assessment and management | Guidance | NICE. [cited 2023 Oct 26]; Available from: https:// www.nice.org.uk/guidance/ng14/chapter/Recommendations
Michielin O, van Akkooi A, Lorigan P, Ascierto PA, Dummer R, Robert C, et al. ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee. Ann Oncol [Internet]. 2020 Nov;31(11):1449–61. Available from: http://dx.doi.org/10.1016/j.annonc.2020.07.005
Ferioli M, Galuppi A, Buwenge M, Cammelli S, Perrone AM, Macchia G, et al. Electrochemotherapy in Kaposi sarcoma: A systematic review. Mol Clin Oncol [Internet]. 2021 Apr;14(4):64. Available from: http://dx.doi.org/10.3892/mco.2021.2226
Manca G, Pandolfi P, Gregorelli C, Cadossi M, de Terlizzi F. Treatment of keloids and hypertrophic scars with bleomycin and electroporation. Plast Reconstr Surg [Internet]. 2013 Oct;132(4):621e – 630e. Available from: http://dx.doi.org/10.1097/ PRS.0b013e3182a053c8
Granata V, Fusco R, D’Alessio V, Simonetti I, Grassi F, Silvestro L, et al. Percutanous Electrochemotherapy (ECT) in Primary and Secondary Liver Malignancies: A Systematic Review. Diagnostics [Internet]. 2023 Jan 5 [cited 2023 Oct 1];13(2):209. Available from: https://www.mdpi.com/2075-4418/13/2/209
Izzo F, Granata V, Fusco R, D’Alessio V, Petrillo A, Lastoria S, et al. Clinical Phase I/II Study: Local Disease Control and Survival in Locally Advanced Pancreatic Cancer Treated with Electrochemotherapy. J Clin Med Res [Internet]. 2021 Mar 22;10(6). Available from: http://dx.doi.org/10.3390/jcm10061305
Deschamps F, Tselikas L, Yevich S, Bonnet B, Roux C, Kobe A, et al. Electrochemotherapy in radiotherapy-resistant epidural spinal cord compression in metastatic cancer patients. Eur J Cancer [Internet]. 2023 Jun 1 [cited 2023 Oct 27];186:62–8. Available from: http://www.ejcancer.com/article/S095980492300148X/abstract
Perrone AM, Corrado G, Coada CA, Garganese G, Fragomeni SM, Tagliaferri L, et al. Electrochemotherapy with intravenous bleomycin for heavily pre-treated vulvar cancer patients. Int J Gynecol Cancer [Internet]. 2023 Apr 1 [cited 2023 Sep 27];33(4). Available from: https://ijgc.bmj.com/content/33/4/473.abstract
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 O Mundo da Saúde
This work is licensed under a Creative Commons Attribution 4.0 International License.
